Regen BioPharma Inc (RGBP)

[cvinvestor]

I too am a bit stunned to find out only 59K shares were traded after this news and less than 10% increase in PPS. I had anticipated much more activity on both levels.

I would add a couple points to others' comments as well:
1. It was a Friday morning PR and that is not optimal.
2. OTC news takes time unless it is a P&D (so good sign we are not in that circumstance and I too think Monday brings in much more investment money and this could/should open at .20 or above based on Friday PR).
3. While we know the history of HemaX filing and FDA approval of other components, others do not, so big money might not react until PR release of actual FDA approval is released
4. Orphan Drug status is guaranteed after FDA approval for clinical trials - which should also move the price
5. Koos/Cavens might be timing some of the PRs to coincide with the presentation at CIRM meeting in CA (Oct 7-9)
6. Getting FDA approval notification around the time of the CIRM stem cell annual mtg could really be beneficial to RGBP catching the eye of some CA venture capitalists.

More good things to come. While price movement on Friday is disappointing, the real positive is that positive test results which should give everyone here more confidence for the future of the company.

My 2 cents:

1. We are listed on a highly manipulative exchange
2. Koos promised and promised for years, and only as of the last 1-2 years has significant, verifiable progress been tangible.
3. Also, during those years of "seemingly nothing" (takes time), dilution was rampant, with no "tangible results".
4. Thus, people still feel the past, and are justifiable skeptical of Koos.

The science seems sound and is obviously getting real world attention, without rebuttal. Wrapped in a different wrapper, we might be at $5 right now.

FDA approval will be a big step forward. Again, for me, I am here not for Koos, but for the doctors and the science.

Just opining.

RGBP